Current Opinion in Ophthalmology was launched in 1990. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of Ophthalmology is divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Robert C. Sergott
Robert C. Sergott, MD, is co-director of the neuro-ophthalmology service and attending surgeon at Wills Eye Hospital, Philadelphia, Pa. He is also professor of ophthalmology, neurology, and neurosurgery at Thomas Jefferson University. He has authored over 200 articles in peer-reviewed journals and lectured at many national and international meetings. He has been the recipient of grant support from the National Eye Institute, National Institutes of Health, Neurology Division, and the National Multiple Sclerosis Society. In 1996, the chairmen of academic ophthalmology departments in the USA elected him one of the 100 best ophthalmologists in America. He has been involved with clinical and research tele-ophthalmology for the last 10 years, concentrating upon thyroid eye disease, multiple sclerosis and optic neuritis, and ischemic optic neuropathy.
Dr Read is the founding director of the Uveitis and Ocular Inflammatory Diseases Service of the University of Alabama at Birmingham Department of Ophthalmology, where he serves as an Associate Professor of Ophthalmology and Pathology. He is also director of the UAB Ocular Immunology and Ophthalmic Pathology Laboratories at UAB. Dr Read is active in the clinical care of patients with uveitis and ocular inflammatory diseases. He has been elected by his peers for inclusion from 2005 to 2008 in the Best Doctors in America. In addition to clinical care of uveitis patients, Dr Read has been funded by the National Eye Institute/NIH and the EyeSight Foundation of Alabama to perform basic research on the role of complement in experimental autoimmune uveitis, an animal model of uveitis. Dr Read is a Research to Prevent Blindness Physician-Scientist. He serves as the Executive Secretary of the American Uveitis Society.